The MarketReader Minute
π Halozyme Soars on Strong Earnings, Sarepta Plunges After Guidance Cut | Biotech Sector Insights
Within the ETF's holdings, significant declines were noted for several companies: Vertex Pharmaceuticals (VRTX) dropped, while Sarepta Therapeutics (SRPT) fell sharply.